Description
GLOTRAX-TZ 562.5 Injection is a broad-spectrum antibiotic combination designed to combat beta-lactamase-producing bacteria. The addition of Tazobactam enhances the efficacy of Ceftriaxone, making it effective against resistant strains.
Mechanism of Action
- Ceftriaxone: A third-generation cephalosporin that inhibits bacterial cell wall synthesis
- Tazobactam: A beta-lactamase inhibitor that protects Ceftriaxone from enzymatic degradation
Indications
- Respiratory tract infections
- Urinary tract infections (UTIs)
- Intra-abdominal infections
- Skin & soft tissue infections
- Bone & joint infections
- Septicemia and severe bacterial infections
Key Benefits
- Enhanced activity against resistant bacteria
- Broad-spectrum bactericidal action
- Suitable for moderate to severe infections
- Reliable IM/IV administration
Dosage & Administration
- For Intramuscular (IM) or Intravenous (IV) use only
- Dosage depends on infection severity and patient condition
- Reconstitute with appropriate diluent before administration
Precautions
- Use under medical supervision only
- Check for penicillin/cephalosporin allergy
- Monitor renal and hepatic function in prolonged use
- Avoid unnecessary use to prevent antibiotic resistance
Storage
- Store in a cool, dry place below 25°C
- Protect from light
- Use immediately after reconstitution
